{"entity":{"type":"insider","cik":"0001775429","url":"/insider/0001775429","json_url":"/insider/0001775429.json","name":"Vignola Mark J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2022-06-08","last":"2025-01-06","span_basis":"filed_date"},"name_variants":[{"name":"Vignola Mark J.","source":"filing","n_filings":7,"first_seen":"2022-06-08","last_seen":"2025-01-06"}],"transactions":[{"id":4288444,"accession":"0001562180-25-000220","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-000220","line_url":"/filing/0001562180-25-000220#line-2","is_derivative":false,"issuer_cik":"0001775429","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001775429","owner_cik":"0001775429","owner_name":"Vignola Mark J.","owner_url":"/insider/0001775429","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9059.0,"shares_display":"9,059","price_per_share":5.7953,"price_display":"5.80","price_state":"stated","total_value":52499.6227,"total_display":"52,499.62","shares_owned_after":74752.0,"shares_owned_after_display":"74,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-06","scope":"insider"},{"id":4288439,"accession":"0001562180-25-000220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-000220","line_url":"/filing/0001562180-25-000220#line-1","is_derivative":false,"issuer_cik":"0001775429","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001775429","owner_cik":"0001775429","owner_name":"Vignola Mark J.","owner_url":"/insider/0001775429","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8129.0,"shares_display":"8,129","price_per_share":5.7232,"price_display":"5.72","price_state":"stated","total_value":46523.8928,"total_display":"46,523.89","shares_owned_after":83811.0,"shares_owned_after_display":"83,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":2318984,"accession":"0001562180-24-006794","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-006794","line_url":"/filing/0001562180-24-006794#line-2","is_derivative":false,"issuer_cik":"0001775429","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001775429","owner_cik":"0001775429","owner_name":"Vignola Mark J.","owner_url":"/insider/0001775429","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":110000.0,"total_display":"110,000.00","shares_owned_after":91940.0,"shares_owned_after_display":"91,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2161258,"accession":"0001562180-24-004665","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-004665","line_url":"/filing/0001562180-24-004665#line-1","is_derivative":false,"issuer_cik":"0001775429","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001775429","owner_cik":"0001775429","owner_name":"Vignola Mark J.","owner_url":"/insider/0001775429","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4791.0,"shares_display":"4,791","price_per_share":4.44,"price_display":"4.44","price_state":"stated","total_value":21272.04,"total_display":"21,272.04","shares_owned_after":91940.0,"shares_owned_after_display":"91,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-04","scope":"insider"},{"id":8714579,"accession":"0001562180-23-008065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-008065","line_url":"/filing/0001562180-23-008065#line-1","is_derivative":false,"issuer_cik":"0001775429","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001775429","owner_cik":"0001775429","owner_name":"Vignola Mark J.","owner_url":"/insider/0001775429","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":743.0,"shares_display":"743","price_per_share":3.78,"price_display":"3.78","price_state":"stated","total_value":2808.54,"total_display":"2,808.54","shares_owned_after":18399.0,"shares_owned_after_display":"18,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-04","scope":"insider"},{"id":8398275,"accession":"0001562180-23-004748","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-004748","line_url":"/filing/0001562180-23-004748#line-1","is_derivative":false,"issuer_cik":"0001775429","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001775429","owner_cik":"0001775429","owner_name":"Vignola Mark J.","owner_url":"/insider/0001775429","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9997.0,"shares_display":"9,997","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":14095.77,"total_display":"14,095.77","shares_owned_after":17656.0,"shares_owned_after_display":"17,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":8633562,"accession":"0001562180-23-000982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-000982","line_url":"/filing/0001562180-23-000982#line-1","is_derivative":false,"issuer_cik":"0001775429","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001775429","owner_cik":"0001775429","owner_name":"Vignola Mark J.","owner_url":"/insider/0001775429","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3.0,"shares_display":"3","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":4.23,"total_display":"4.23","shares_owned_after":7659.0,"shares_owned_after_display":"7,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-30","filed_date":"2023-02-03","scope":"insider"},{"id":6572342,"accession":"0001562180-22-004951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-004951","line_url":"/filing/0001562180-22-004951#line-1","is_derivative":false,"issuer_cik":"0001775429","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001775429","owner_cik":"0001775429","owner_name":"Vignola Mark J.","owner_url":"/insider/0001775429","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7656.0,"shares_display":"7,656","price_per_share":1.47,"price_display":"1.47","price_state":"stated","total_value":11254.32,"total_display":"11,254.32","shares_owned_after":7656.0,"shares_owned_after_display":"7,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-08","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831363","name":"Terns Pharmaceuticals, Inc.","url":"/issuer/0001831363","role":"Officer (Chief Financial Officer)","n_filings":7,"first_seen":"2022-06-08","last_seen":"2025-01-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001775429","retrieved_at":"2026-08-21T16:32:02+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}